Effect of Testosterone on Proliferation Markers and Apoptosis in Breasts of Ovariectomized Rats

被引:0
作者
Conceicao Oliveira, Jussara Celi [1 ]
Steiner, Marcelo Luis [2 ]
Theodoro, Therese Rachell [3 ]
Amaral Antonio Mader, Ana Maria [4 ]
Petri, Giuliana [5 ]
Abreu, Luiz Carlos [6 ]
da Silva Pinhal, Maria Aparecida [3 ]
Fernandes, Cesar Eduardo [2 ]
Pompei, Luciano Melo [2 ]
机构
[1] Fundacao ABC, Fac Med ABC, Rua Procopio Ribeiro dos Santos 84, BR-04664130 Santo Andre, SP, Brazil
[2] Fac Med ABC, Dept Gynecol & Obstet, Santo Andre, SP, Brazil
[3] Fac Med ABC, Dept Biochem, Santo Andre, SP, Brazil
[4] Fac Med ABC, Dept Pathol, Santo Andre, SP, Brazil
[5] Fac Med ABC, Biottery Coordinat, Santo Andre, SP, Brazil
[6] Fac Med ABC, Outline & Sci Writing Lab, Santo Andre, SP, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2019年 / 41卷 / 12期
关键词
testosterone; proliferation; apoptosis; breast; ovariectomy; POSTMENOPAUSAL WOMEN; CANCER RISK; ANDROGENS; HORMONES; SAFETY;
D O I
10.1055/s-0039-3399552
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To investigate the action of testosterone (T), isolated or associated with estradiol benzoate (EB), on the proliferation markers and apoptosis of breasts of ovariectomized rats. Methods A total of 48 castrated female Wistar rats were divided into 6 groups, and each of them were submitted to one of the following treatments for 5 weeks: 1) control; 2) EB 50 mcg/day - T 50mcg/day; 3) T 50mcg/day; 4) EB 50 mcg + T 300 mcg/day; 5) T 300 mcg/day; and 6) EB 50 mcg/day. After the treatment, the mammary tissue was submitted to a histological analysis and immunoexpression evaluation of proliferation markers (proliferating cell nuclear antigen, PCNA) and apoptosis (caspase-3). Results There was a statistically significant difference among the groups regarding microcalcifications and secretory activity, with higher prevalence in the groups treated with EB. There was no difference among the groups regarding atrophy, but a higher prevalence of atrophy was found in the groups that received T versus those that received EB + T. There was a difference among the groups regarding the PCNA (p = 0.028), with higher expression in the group submitted to EB + T 300 mcg/day. Regarding caspase-3, there was no difference among the groups; however, in the group submitted to EB + T 300 mcg/day, the expression was higher than in the isolated T group. Conclusion Isolated T did not have a proliferative effect on the mammary tissue, contrary to EB. Testosterone in combination with EB may or may not decrease the proliferation, depending on the dose of T.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 17 条
  • [1] Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women
    Baglietto, Laura
    Severi, Gianluca
    English, Dallas R.
    Krishnan, Kavitha
    Hopper, John L.
    McLean, Catriona
    Morris, Howard A.
    Tilley, Wayne D.
    Giles, Graham G.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 492 - 502
  • [2] Safety and adverse effects of androgens: How to counsel patients
    Basaria, S
    Dobs, AS
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (04) : S25 - S32
  • [3] Steroid receptors and proliferation in the human breast
    Clarke, RB
    [J]. STEROIDS, 2003, 68 (10-13) : 789 - 794
  • [4] Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
    Davis, Susan R.
    Moreau, Michele
    Kroll, Robin
    Bouchard, Celine
    Panay, Nick
    Gass, Margery
    Braunstein, Glenn D.
    Hirschberg, Angelica Linden
    Rodenberg, Cynthia
    Pack, Simon
    Koch, Helga
    Moufarege, Alain
    Studd, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) : 2005 - 2017
  • [5] Testosterone in women-the clinical significance
    Davis, Susan R.
    Wahlin-Jacobsen, Sarah
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (12) : 980 - 992
  • [6] Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606
  • [7] Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population
    Grynberg, Michael
    Fanchin, Renato
    Dubost, Genevieve
    Colau, Jean-Claude
    Bremont-Weil, Catherine
    Frydman, Rene
    Ayoubi, Jean-Marc
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2010, 20 (04) : 553 - 558
  • [8] Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women
    Hofling, Marie
    Hirschberg, Angelica Linden
    Skoog, Lambert
    Tani, Edneia
    Hagerstrom, Torsten
    von Schoultz, Bo
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (02): : 183 - 190
  • [9] Postmenopausal serum androgens, oestrogens and breast cancer risk:: the European prospective investigation into cancer and nutrition
    Kaaks, R
    Rinaldi, S
    Key, TJ
    Berrino, F
    Peeters, PHM
    Biessy, C
    Dossus, L
    Lukanova, A
    Binghan, S
    Khaw, KTG
    Allen, NE
    Bueno-De-Mesquita, HB
    van Gils, CH
    Grobbee, D
    Boeing, H
    Lahmann, PH
    Nagel, G
    Chang-Claude, J
    Clavel-Chapelon, F
    Fournier, A
    Thiébaut, A
    González, CA
    Quirós, JR
    Tormo, MJ
    Ardanaz, E
    Amiano, P
    Krogh, V
    Palli, D
    Panico, S
    Tumino, R
    Vineis, P
    Trichopoulou, A
    Kalapothaki, V
    Trichopoulos, D
    Ferrari, P
    Norat, T
    Saracci, R
    Riboli, E
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 1071 - 1082
  • [10] Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
    Manjer, J
    Johansson, R
    Berglund, G
    Janzon, L
    Kaaks, R
    Ågren, Å
    Lenner, P
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (07) : 599 - 607